daiichi sankyo co ltd
(4568:Tokyo Stock Exchange)
Transactions by DAIICHI SANKYO CO LTD (4568) in the last 6 months
Kitasato Daiichi Sankyo Vaccine Co., Ltd. announced that it has received ¥10,000,005,000 in an equity round of funding on June 30, 2015. The transaction included participation from existing investor, Daiichi Sankyo Company, Limited. As part of the transaction, ¥5,000,002,500 will be transferred to the registered capital of the company and the balance of ¥5,000,002,500 will be transferred to its capital reserve. On closing, the investor now holds 80% stake in the company. ...
Daiichi Sankyo Company, Limited (TSE:4568) announces a share repurchase program. Under the program, the company will repurchase up to 28,000,000 shares, representing 3.98% of its share capital for ¥50,000 million. The shares will be repurchased in order to attempt the enhancement of shareholder returns and the improvement of capital efficiency. The plan will expire on August 31, 2015. As of March 31, 2015, the company has 704,028,172 outstanding shares (excluding treasury ...
|BioCryst Pharmaceuticals Inc||$15.06 USD||-0.06|
|Exelixis Inc||$5.44 USD||-0.15|
|Ipsen SA||€55.52 EUR||-1.39|
|Vertex Pharmaceuticals Inc||$123.23 USD||-2.27|
|View Industry Companies|